諾普信(002215.SZ)股東潤寶盈信質押展期2025萬股
格隆匯11月1日丨諾普信(002215.SZ)公佈,公司於近日收到公司股東西藏林芝潤寶盈信實業投資有限公司(“潤寶盈信”)的通知,獲悉潤寶盈信所持有的公司的部分股份質押展期,質押展期2025萬股,佔其所持股份比例79.90%。
截至公告日,潤寶盈信共持有公司股票2534.32萬股,佔公司總股本的2.77%,潤寶盈信累計質押其持有的公司股份2025萬股,佔潤寶盈信持有公司股份總數的79.90%,佔公司總股本的2.22%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.